In an effort to promote the wise clinical practice, the American Board of Internal Medicine (ABIM) has launched an initiative called “ Choosing Wisely” to formulate a discussion among physicians and medical specialists by identifying tests or procedures commonly used in their field whose necessity should be questioned and evaluated. This article provides an insight into some restrictions that should be followed in breast cancer management.
Routine MRI in new breast cancer patients has NO significant benefit There is a lack of evidence that routine use of MRI lessens cancer recurrence, death from cancer or the need for re-operation after lumpectomy surgery. The routine use of MRI is associated with the following risks An increased need for subsequent breast biopsy procedures Delays in time to treatment and higher cost of care Detection of additional cancers or indeterminate findings…
